Arch Capital Group Multi-line and other specialty — Year Ten decreased by 71.4% to 0.4% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 71.4%, from 1.4% to 0.4%. This decline may warrant attention — for this metric, higher values are generally preferred.
Strong performance at the ten-year mark demonstrates a mature, well-managed segment with sustainable competitive advantages.
This metric represents the financial performance of the multi-line and specialty insurance segment for the tenth year of...
Comparable to decade-long segment performance analysis provided by established insurance and reinsurance market participants.
acgl_segment_multi_line_and_other_specialty_year_ten| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | -0.1% | 0% | 0.5% | 1.4% | 0.4% |
| QoQ Change | — | +100.0% | — | +180.0% | -71.4% |
| YoY Change | — | +100.0% | — | +180.0% | -71.4% |